Marine

Post-doctoral fellow @EPFL. Passionate about oncology and tumor immunology

[EPFL @EPFL_en]

Cancer treatments often struggle with balancing efficacy and side effects. A new study @epflsv offers a solution using antibody-peptide inhibitor conjugates to target specific cell types and block the activity of cancer-promoting enzymes called cathepsins.
https://t.co/OCmBnIAx0m

[Ludwig Cancer @Ludwig_Cancer]

Ludwig @OncoUNILCHUV's @IrvingMelita, former grad student Evangelos Stefanidis & team report a two-pronged attack strategy to simultaneously drive T cell & macrophage attack on tumors. Adding therapeutic antibodies to the mix boosts cancer cell targeting. https://t.co/3StRdoObOv

[Justine Epiney @EpineyJustine]

Getting warmed up in Rimini for round 2 of the fabulous #EmboWorkshop ☀️

[Matteo Morotti @MMorotti]

Proud to share the results of our study on the effect of prostaglandin E2 on T cells, which was just published in Nature in which we discovered a new role for PGE2 in inhibiting interleukin-2 (IL-2) sensing and signalling in tumor-reactive T cells https://t.co/9Pu6cy0JvA

[Marine @MarineBruand]

Proud of @RuxandraLambuta who presented her great work at the
ISREC-SCCL Symposium 2023 #ISREC2023

[Justine Epiney @EpineyJustine]

Our fab @RuxandraLambuta rocking the stage again with her work on whole genome duplication, which was recently published in @Nature!

If you didn’t get enough ➡️ https://t.co/mMOzeMtpBa

#ISREC2023

[EPFL Life Sciences @epflSV]

Exiting Opening of the ISREC SCCL Symposium @SwissTech_EPFL today. 300 scientists meet to unlock the Horizons of #CancerBiology and #PrecisionOncoloy.
Follow 👉 #ISREC2023 !

#PrecisionMedicine #CancerResearch #ScientificConference #InnovationInScience

[Marine @MarineBruand]

Congratulations to our new Doctor @RuxandraLambuta ! Amazing job 🥳

[Marine @MarineBruand]

Very proud of my colleague and friend @EpineyJustine

[Oncology UNIL CHUV @OncoUNILCHUV]

The front cover article @ScienceTM: Multispectral MRI allows researchers to track the behavior of macrophages in cancer with temporal, spatial and cellular resolution.

📑https://t.co/YSotD0XT6B

By @JoyceLab @unil @CHUVLausanne @Ludwig_Cancer

[Frontiers - Immunology @FrontImmunol]

New Research: CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues: Chimeric antigen receptor (CAR) T cells have emerged as a powerful immunotherapeutic tool against certain… https://t.co/6Pwd3EMeHx #immunology

[P. Oster @Sci_Paul_Oster]

Thank you Dr. R. de Wijn form the @EuropeanXFEL for the tour and all explanation about the instrument and experiments that are made a #XFEL !
Crystallography is more fun and understandable now !

[P. Oster @Sci_Paul_Oster]

[New paper] Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors https://t.co/0DHZHgPqsM

I'm happy to see that other people have found identical results that in our paper !

[Marine @MarineBruand]

@PetrovaLab Congratulations !!

[Faculté de biologie et de médecine (inactif) @FBM_UNIL]

Programme national MD-PhD: félicitations 👏 aux 4 lauréat·e·s de Lausanne
➡️https://t.co/0vn0VJZYyK

@FBM_UNIL @unil @CHUVLausanne
@EpineyJustine @FondationIsrec @epflSV @EPFLEngineering @fns_ch @academies_ch @SSPHplus @UNIGEnews

ⒸAcadémie Suisse des Sciences Médicales (ASSM)

[Marine @MarineBruand]

@VozeninC @OncoUNILCHUV @FBM_UNIL @unil @Ludwig_Cancer @elisa_oricchio @epflSV @CHUVLausanne Thank you Marie-Catherine !

[Marine @MarineBruand]

@IrvingMelita @OncoUNILCHUV @FBM_UNIL @unil @Ludwig_Cancer @elisa_oricchio @epflSV @CHUVLausanne Thank you Melita !

[Oncology UNIL CHUV @OncoUNILCHUV]

Super proud that three of our young researchers are among recipients of @FBM_UNIL 2022 awards!

First up, 𝑴𝒂𝒓𝒊𝒏𝒆 𝑩𝒓𝒖𝒂𝒏𝒅 awarded a ℙ𝕣𝕚𝕩 𝕕𝕖 𝔽𝕒𝕔𝕦𝕝𝕥é for her PhD thesis in the Dangaj Lab/Hi-TIDe @unil @Ludwig_Cancer. Marine is now with @elisa_oricchio @epflSV!